Citation Impact
Citing Papers
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
2010 StandoutScience
( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
2013 StandoutScienceNobel
Leukemia in twins: lessons in natural history
2003
Signal Transduction by the JNK Group of MAP Kinases
2000 Standout
Oncogenic kinase signalling
2001 StandoutNature
Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL
1997
Chromatin structural elements and chromosomal translocations in leukemia
2006
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Anaplastic lymphoma kinase proteins in growth control and cancer
2004
Autophagy regulates lipid metabolism
2009 StandoutNature
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
Thicker Than Blood
2003
Smad-dependent and Smad-independent pathways in TGF-β family signalling
2003 StandoutNature
Stat3 as an Oncogene
1999 Standout
High-Resolution Profiling of Histone Methylations in the Human Genome
2007 Standout
Jaks and cytokine receptors—An intimate relationship
2006
Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes
1998
Genomic organization of human JAK2 and mutation analysis of its JH2-domain in leukemia
1999
CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients
1999
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Cell Death
2004 Standout
Origins and functions of phagocytes in the embryo
2000
Eater, a Transmembrane Protein Mediating Phagocytosis of Bacterial Pathogens in Drosophila
2005 StandoutNobel
Bcl10 and MALT1, Independent Targets of Chromosomal Translocation in MALT Lymphoma, Cooperate in a Novel NF-κB Signaling Pathway
2001
Missing Pieces in the NF-κB Puzzle
2002 Standout
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Carma1, a CARD‐containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF‐κB activation1
2001
Breaking the chains: structure and function of the deubiquitinases
2009 Standout
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma
2003
Apoptosis
2002 Standout
Antisense therapy in oncology: new hope for an old idea?
2001
IAP proteins: blocking the road to death's door
2002
Selective C-Rel Activation via Malt1 Controls Anti-Fungal TH-17 Immunity by Dectin-1 and Dectin-2
2011
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
2004 StandoutNature
The E3 Ubiquitin Ligase Mind Bomb-2 (MIB2) Protein Controls B-cell CLL/Lymphoma 10 (BCL10)-dependent NF-κB Activation
2011
Death and anti-death: tumour resistance to apoptosis
2002 Standout
The Evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death
2000
Stat5 Is Essential for the Myelo- and Lymphoproliferative Disease Induced by TEL/JAK2
2000
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Surrogate Wnt agonists that phenocopy canonical Wnt and β-catenin signalling
2017 StandoutNatureNobel
Molecular genetics, natural history and the demise of childhood leukaemia
1999
JAK2, complemented by a second signal from c-kit or flt-3, triggers extensive self-renewal of primary multipotential hemopoietic cells
2002
Clonal evolution in cancer
2012 StandoutNature
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α
1998 StandoutNobel
A surprising simplicity to protein folding
2000 StandoutNatureNobel
CARMA1, BCL-10 and MALT1 in lymphocyte development and activation
2004
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Cytosolic 5′-Triphosphate Ended Viral Leader Transcript of Measles Virus as Activator of the RIG I-Mediated Interferon Response
2007
Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells
2009
Therapeutic targeting of Janus kinases
2008
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Dynamics of CRISPR-Cas9 genome interrogation in living cells
2015 StandoutScienceNobel
The gastric marginal zone B-cell lymphoma of MALT type
2000
TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers.
2000
B Cell Signaling and Fate Decision
2009
The Protein Kinase Complement of the Human Genome
2002 StandoutScience
HaloTag: A Novel Protein Labeling Technology for Cell Imaging and Protein Analysis
2008 Standout
Superresolution Imaging of Targeted Proteins in Fixed and Living Cells Using Photoactivatable Organic Fluorophores
2010 StandoutNobel
Genomes in Focus: Development and Applications of CRISPR‐Cas9 Imaging Technologies
2017 StandoutNobel
A TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia
1997 Science
Identification and Characterization of a Constitutively Active STAT5 Mutant That Promotes Cell Proliferation
1998
Identification of Paracaspases and Metacaspases
2000
Targeting ALK: Precision Medicine Takes on Drug Resistance
2017
Fluorophore Targeting to Cellular Proteins via Enzyme-Mediated Azide Ligation and Strain-Promoted Cycloaddition
2012 StandoutNobel
Chromosome translocations and covert leukemic clones are generated during normal fetal development
2002
After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies
2004
Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice
2002 StandoutNobel
Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids
2000 StandoutNobel
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
RNAi-mediated immunity provides strong protection against the negative-strand RNA vesicular stomatitis virus in Drosophila
2010 StandoutNobel
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas
2005
Structure of the Ets-1 pointed domain and mitogen-activated protein kinase phosphorylation site
1998
Unique Substrate Specificity of Anaplastic Lymphoma Kinase (ALK): Development of Phosphoacceptor Peptides for the Assay of ALK Activity
2005
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia
1996
The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion
2000
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
The Host Defense of Drosophila melanogaster
2007 StandoutNobel
The gastric marginal zone B-cell lymphoma of MALT type
2000
Negative Regulation of Cytokine Signaling Pathways
2000 Standout
Use and Abuse of RNAi to Study Mammalian Gene Function
2012 StandoutScienceNobel
Essential Role of Survivin, an Inhibitor of Apoptosis Protein, in T Cell Development, Maturation, and Homeostasis
2003
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
2004 Standout
Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice
2008 StandoutNobel
T Cell Activation
2009 Standout
E3 ubiquitin ligase Mindbomb 1 facilitates nuclear delivery of adenovirus genomes
2020 StandoutNobel
Computational design of a red fluorophore ligase for site-specific protein labeling in living cells
2014 StandoutNobel
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
2004 Standout
Autophagy in Health and Disease: A Double-Edged Sword
2004 StandoutScience
Works of Mathijs Baens being referenced
A Human Homologue (BICD1) of theDrosophila Bicaudal-DGene
1997
The Dark Side of EGFP: Defective Polyubiquitination
2006
Structure of theMLT gene and molecular characterization of the genomic breakpoint junctions in the t(11;18)(q21;q21) of marginal zone B-cell lymphomas of MALT type
2000
A Novel TRAF6 Binding Site in MALT1 Defines Distinct Mechanisms of NF-κB Activation by API2·MALT1 Fusions
2007
T cell antigen receptor stimulation induces MALT1 paracaspase–mediated cleavage of the NF-κB inhibitor A20
2008
Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization
1993
Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLTspecific probes
2000
Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid Leukemia
1997
Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders.
1997
Fluorescence in situ hybridization analysis of t(3; 12)(q26; p13): a recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes
1996
ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma
2003
Genomic organization of TEL: the human ETS-variant gene 6.
1996
Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions
2000
The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia
1996
The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene,MLT, Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated Lymphoid Tissue Lymphomas
1999
The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene,MLT, Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated Lymphoid Tissue Lymphomas
1999
Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid Leukemia
1997
A novel N-ras mutation in malignant melanoma is associated with excellent prognosis.
2001